The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
287.70
-2.60 (-0.90%)
At close: Mar 27, 2025
10.19%
Market Cap 8.99B
Revenue (ttm) 11.48B
Net Income (ttm) 593.81M
Shares Out 31.24M
EPS (ttm) 19.01
PE Ratio 15.14
Forward PE 12.45
Dividend 6.30 (2.19%)
Ex-Dividend Date Oct 28, 2024
Volume 16,058
Average Volume 16,006
Open 290.30
Previous Close 290.30
Day's Range 286.50 - 290.30
52-Week Range 223.50 - 384.80
Beta 0.26
RSI 37.20
Earnings Date Apr 24, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Employees 4,200
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBNSINA
Full Company Profile

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.

Financial Statements

News

There is no news available yet.